Patient-Level Medication Regimen Complexity Across Populations With Chronic Disease

Clinical Therapeutics

Volumn 35, Issue 4, 2013, Pages

  Libby, Anne M ^a,b   Fish, Douglas N ^a   Hosokawa, Patrick W ^b   Linnebur, Sunny A ^a   Metz, Kelli R ^a   Nair, Kavita V ^a   Saseen, Joseph J ^a   Vande Griend, Joseph P ^a   Vu, Sara P ^a   Hirsch, Jan D ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic disease; Comorbidities; Diabetes; Geriatric depression; HIV; Hypertension; Medication regimen complexity; MRCI

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIRETROVIRUS AGENT; NON PRESCRIPTION DRUG; PRESCRIPTION DRUG;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; ELECTRONIC MEDICAL RECORD; GERIATRIC DISORDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; PRESCRIPTION; RETROSPECTIVE STUDY;

EID: 84876307103     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2013.02.019     Document Type: Article

References (46)

1. Dragomir A., Cote R., Roy L., et al. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care 2010, 48:418-425.
2. Krousel-Wood M., Islam T., Muntner P., et al. Association of depression with antihypertensive medication adherence in older adults: cross-sectional and longitudinal findings from CoSMO. Ann Behav Med 2010, 40:248-257.
3. May H.T., Sheng X., Catinella A.P., et al. Antilipidemic adherence post-coronary artery disease diagnosis among those with and without an ICD-9 diagnosis of depression. J Psychos Res 2010, 69:169-174.
4. Mazzaglia G., Ambrosioni E., Alacqua M., et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009, 120:1598-1605.
5. McLean D.L., McAlister F.A., Johnson J.A., et al. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med 2008, 168:2355-2361.
6. Carter B.L., Bergus G.R., Dawson J.D., et al. A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. J Clin Hyperten 2008, 10:260-271.
7. Bhatt D.L., Scheiman J., Abraham N.S., et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2008, 52:1502-1517.
8. Blanco F., San Román J., Vispo E., et al. Management of metabolic complications and cardiovascular risk in HIV-infected patients. AIDS Review 2010, 12:231-241.
9. Feigenbaum K., Longstaff L. Management of the metabolic syndrome in patients with human immunodeficiency virus. Diabetes Educ 2010, 36:457-464.
10. Gopal M., Bhaskaran A., Khalife W., Barbagelata A. Heart disease in patients with HIV/AIDS-an emerging clinical problem. Curr Cardiol Rev 2009, 5:149-154.
11. Kaul S., Bolger A.F., Herrington D., et al. Thiazolidinedione drugs and cardiovascular risks: a science advisory from the American Heart Association and American College Of Cardiology Foundation. J Am Coll Cardiol 2010, 55:1885-1894.
12. Osborn C.Y., Cavanaugh K., Wallston K.A., et al. Diabetes numeracy: an overlooked factor in understanding racial disparities in glycemic control. Diabetes Care 2009, 32:1614-1619.
13. Schillinger D., Grumbach K., Piette J., et al. Association of health literacy with diabetes outcomes. JAMA 2002, 288:475-482.
14. Wiysonge C.S., Bradley H., Mayosi B.M., et al. Beta-blockers for hypertension. Cochrane Database Syst Rev 2007, (1). CD002003.
15. Ingersoll K.S., Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med 2008, 31:213-224.
16. Morisky D.E., Ang A., Krousel-Wood M., Ward H.J. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hyperten 2008, 10:348-354.
17. Lewin G. Medication therapy management services: a critical review. J Am Pharm Assoc 2005, 45:580-587.
18. Berry S.D., Quach L., Procter-Gray E., et al. Poor adherence to medications may be associated with falls. J Gerontol A Biol Sci Med Sci 2010, 65:553-558.
19. Ma A., Chen D.M., Chau F.M., Saberi P. Improving adherence and clinical outcomes through an HIV pharmacist's interventions. AIDS Care 2010, 22:1189-1194.
20. George J., Phun Y.T., Bailey M.J., et al. Development and validation of the medication regimen complexity index. Ann Pharmacother 2004, 38:1369-1376.
21. Pollack M., Chastek B., Williams S.A. "PDB36 Impact of Treatment Complexity on Adherence and Glycemic Control: An Analysis of Oral Anti-Diabetic Agents.". Value Health 2009, 3:A103.
22. Cardone K.E., Manley H.J., Grabe D.W., et al. Quantifying home medication regimen changes and quality of life in patients receiving nocturnal home hemodialysis. Hemodial Int 2011, 15:234-242.
23. Correr C.J., Melchiors A.C., Fernandez-Llimos F., Pontarolo R. Effects of a pharmacotherapy follow-up in community pharmacies on type 2 diabetes patients in Brazil. Int J Clin Pharm 2011, 33:273-280.
24. Hayes K.S. Adding medications in the emergency department: effect on knowledge of medications in older adults. J Emerg Med 1999, 25:178-182.
25. Farris K.D., Kelly M.W., Tryon J. Clock drawing test and medication complexity index as indicators of medication management capacity: a pilot study. J Am Pharm Assoc (Wash) 2003, 43:78-81.
26. Melchiors A.C., Correr C.J., Fernandez-Llimos F. Translation and validation into Portuguese language of the medication regimen complexity index. Arq Bras Cardiol 2007, 89:210-218.
27. Barnason S., Zimmerman L., Hertzog M., Schulz P. Pilot testing of a medication self-management transition intervention for heart failure patients. West J Nurs Res 2010, 32:849-870.
28. Frohlich S.E., Zaccolo A.V., da Silva S.L., Mengue S.S. Association between drug prescribing and quality of life in primary care. Pharm World Sci 2010, 32:744-751.
29. Dierich M.T., Mueller C., Westra B.L. Medication regimens in older home care patients. J Gerontol Nurs 2011, 37:45-55.
30. Mansur N., Weiss A., Beloosesky Y. Looking beyond polypharmacy: quantification of medication regimen complexity in the elderly. Am J Geriatr Pharmacother 2012, 10:223-229.
31. Stange D., Kriston L., Langebrake C., et al. Development and psychometric evaluation of the German version of the Medication Regimen Complexity Index (MRCI-D). J Eval Clin Pract 2012, 18:515-522.
32. DiIorio C., McDonnell M., McCarty F., Yeager K. Initial testing of the Antiretroviral Medication Complexity Index. J Assoc Nurses AIDS Care 2006, 17:26-36.
33. DiIorio C., Yeager K., Shafer P.O., et al. The epilepsy medication and treatment complexity index: reliability and validity testing. J Neurosci Nurs 2003, 35:155-162.
34. Ferrari C.M., Castro L.H., Settervall C.H., et al. Validity and reliability of the Portuguese version of the Epilepsy Medication Treatment Complexity Index for Brazil. Epilepsy Behav 2011, 21:467-472.
35. Martin S., Wolters P.L., Calabrese S.K., et al. The Antiretroviral Regimen Complexity Index. A novel method of quantifying regimen complexity. J Acquir Immune Defic Syndr 2007, 45:535-544.
36. Yeager K.A., Diiorio C., Shafer P.O., et al. The complexity of treatments for persons with epilepsy. Epilepsy Behav 2005, 7:679-686.
37. Charlson M., Szatrowski T.P., Peterson J., Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994, 47:1245-1251.
38. Facts & Comparisons eAnswers Wolters Kluwer Health, Accessed August 10, 2012. http://online.factsandcomparisons.com.
39. Thompson M.A., Mugavero M.J., Amico K.R., et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med 2012, 156:817-833. W-284, W-285, W-286, W-287, W-288, W-289, W-290, W-291, W-292, W-293, W-294.
40. Llibre J.M., Clotet B. Once-daily single-tablet regimens: a long and winding road to excellence in antiretroviral treatment. AIDS Reviews 2012, 14:168-178.
41. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220.
42. Gupta A.K., Arshad S., Poulter N.R. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension 2010, 55:399-407.
43. Nichols G.A., Kimes T.M., Harp J.B., et al. Glycemic response and attainment of A1C goals following newly initiated insulin therapy for type 2 diabetes. Diabetes Care 2012, 35:495-497. 44.
44. McDonald M.V., Peng T.R., Sridharan S., et al. Automating the medication regimen complexity index. J Am Med Inform Assoc 2012 Dec 25, [Epub ahead of print].
45. Pollack M., Chastek B., Williams S., Moran J. Impact of treatment complexity on adherence and glycemic control: an analysis of oral antidiabetic agents. J Clin Outcomes Manag 2010, 17:257-265.
46. Cobaugh D.J. Advancing pharmacy practice models: Achieving consensus. Am J Health-Syst Pharm 2011, 68:e40-e41.